[1]
2026. THE The Role of Platinum Agents in Neoadjuvant Chemotherapy for BRCA-Associated Triple-Negative Breast Cancer: Preliminary Results of a Single-Center Study. Voprosy onkologii. 72, 3 (Jul. 2026), OF-2667. DOI:https://doi.org/10.37469/0507-3758-2026-72-3-OF-2667.